Shares of health insurance company Clover Health (NASDAQ:CLOV) jumped 2.9% in the morning session after its wholly-owned subsidiary, Counterpart Health, announced a major upgrade to its AI-powered physician-enablement platform with the launch of a new ambient scribing solution.

The new feature, integrated into its Counterpart Assistant, is designed to transform clinical visits into seamless, conversational experiences, aiming to deliver better patient care with less administrative effort for physicians. This technological enhancement for Clover's AI-driven platform is a significant product development. The positive news follows a period of strong performance for the stock, which has already seen a notable increase in its share price over the last month.

After the initial pop the shares cooled down to $2.83, up 3.3% from previous close.

Is now the time to buy Clover Health? Access our full analysis report here, it’s free.

Clover Health’s shares are extremely volatile and have had 31 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 18 days ago when the stock gained 4.6% on the news that the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested that with inflation risks moderating and unemployment remaining low, the Federal Reserve might consider a shift in its monetary policy stance, including potential interest rate cuts. This outlook eased market concerns about prolonged high interest rates and their impact on economic growth. The prospect of lower borrowing costs bolstered investor confidence, particularly in sectors that have lagged, leading to a broad rally across the market.

Clover Health is down 9.7% since the beginning of the year, and at $2.83 per share, it is trading 41.4% below its 52-week high of $4.82 from January 2025. Investors who bought $1,000 worth of Clover Health’s shares 5 years ago would now be looking at an investment worth $254.50.

Unless you’ve been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.